ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly marketing, selling, and administrative ($M) ($M)
Quarterly figures from Eli Lilly's filings and investor materials
Latest, Q2 2026
3,430
Period ended Jun 30, 2026
Change on a year earlier
+24.6%
2,753 in Q2 2025
History
69 quarters
Since Q2 2008
Sources
57
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Marketing, selling, and administrative ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 3,430 | +24.6% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 2,934 | +18.9% | Form 10-Q (filed 2026-04-30) ↗ |
| Q4 2025 | Dec 31, 2025 | 3,131 | +29.1% | Form 10-K (filed 2026-02-12) ↗ |
| Q3 2025 | Sep 30, 2025 | 2,741 | +30.5% | Form 10-Q (filed 2025-10-30) ↗ |
| Q2 2025 | Jun 30, 2025 | 2,753 | +30.0% | Form 10-Q (filed 2025-08-07) ↗ |
| Q1 2025 | Mar 31, 2025 | 2,468 | +26.4% | Form 10-Q (filed 2026-04-30) ↗ |
| Q4 2024 | Dec 31, 2024 | 2,425 | +25.9% | Form 10-K (filed 2026-02-12) ↗ |
| Q3 2024 | Sep 30, 2024 | 2,100 | +16.4% | Form 10-Q (filed 2024-10-30) ↗ |
| Q2 2024 | Jun 30, 2024 | 2,117 | +10.0% | Form 10-Q (filed 2024-08-08) ↗ |
| Q1 2024 | Mar 31, 2024 | 1,952 | +11.6% | Form 10-Q (filed 2024-04-30) ↗ |
| Q4 2023 | Dec 31, 2023 | 1,926 | +17.2% | Form 10-K (filed 2026-02-12) ↗ |
| Q3 2023 | Sep 30, 2023 | 1,804 | +11.8% | Form 10-Q (filed 2023-11-02) ↗ |
| Q2 2023 | Jun 30, 2023 | 1,925 | +18.5% | Form 10-Q (filed 2023-08-08) ↗ |
| Q1 2023 | Mar 31, 2023 | 1,749 | +12.3% | Form 10-Q (filed 2023-04-27) ↗ |
| Q4 2022 | Dec 31, 2022 | 1,643 | +3.2% | Form 10-K (filed 2023-02-22) ↗ |
| Q3 2022 | Sep 30, 2022 | 1,614 | +2.3% | Form 10-Q (filed 2022-11-01) ↗ |
| Q2 2022 | Jun 30, 2022 | 1,625 | -3.6% | Form 10-Q (filed 2022-08-04) ↗ |
| Q1 2022 | Mar 31, 2022 | 1,558 | -1.1% | Form 10-Q (filed 2022-04-29) ↗ |
| Q4 2021 | Dec 31, 2021 | 1,592 | +2.5% | Form 10-K (filed 2022-02-23) ↗ |
| Q3 2021 | Sep 30, 2021 | 1,578 | +0.6% | Form 10-Q (filed 2021-10-27) ↗ |
| Q2 2021 | Jun 30, 2021 | 1,686 | +16.4% | Form 10-Q (filed 2021-08-03) ↗ |
| Q1 2021 | Mar 31, 2021 | 1,576 | +1.7% | Form 10-Q (filed 2021-04-30) ↗ |
| Q4 2020 | Dec 31, 2020 | 1,554 | -8.5% | Form 10-K (filed 2021-02-17) ↗ |
| Q3 2020 | Sep 30, 2020 | 1,569 | +11.1% | Form 10-Q (filed 2020-10-28) ↗ |
| Q2 2020 | Jun 30, 2020 | 1,449 | -8.7% | Form 10-Q (filed 2020-07-31) ↗ |
| Q1 2020 | Mar 31, 2020 | 1,550 | +2.1% | Form 10-Q (filed 2020-05-01) ↗ |
| Q4 2019 | Dec 31, 2019 | 1,698 | +0.3% | Form 10-K (filed 2020-02-19) ↗ |
| Q3 2019 | Sep 30, 2019 | 1,412 | -3.1% | Form 10-Q (filed 2019-10-25) ↗ |
| Q2 2019 | Jun 30, 2019 | 1,586 | +6.8% | Form 10-Q (filed 2019-08-02) ↗ |
| Q1 2019 | Mar 31, 2019 | 1,517 | +13.3% | Form 10-Q (filed 2019-05-02) ↗ |
| Q4 2018 | Dec 31, 2018 | 1,694 | +53.2% | Form 10-K (filed 2020-02-19) ↗ |
| Q3 2018 | Sep 30, 2018 | 1,457 | -7.7% | Form 10-Q (filed 2019-10-25) ↗ |
| Q2 2018 | Jun 30, 2018 | 1,486 | -14.1% | Form 10-Q (filed 2019-08-02) ↗ |
| Q1 2018 | Mar 31, 2018 | 1,339 | -14.6% | Form 10-Q (filed 2019-05-02) ↗ |
| Q4 2017 | Dec 31, 2017 | 1,106 | -40.7% | Form 10-K (filed 2020-02-19) ↗ |
| Q3 2017 | Sep 30, 2017 | 1,579 | +0.8% | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2017 | Jun 30, 2017 | 1,730 | +6.6% | Form 10-Q (filed 2018-07-25) ↗ |
| Q1 2017 | Mar 31, 2017 | 1,568 | +6.4% | Form 10-Q (filed 2018-04-27) ↗ |
| Q4 2016 | Dec 31, 2016 | 1,866 | +3.8% | Form 10-K (filed 2019-02-19) ↗ |
| Q3 2016 | Sep 30, 2016 | 1,565 | -0.7% | Form 10-Q (filed 2016-10-28) ↗ |
| Q2 2016 | Jun 30, 2016 | 1,623 | -0.8% | Form 10-Q (filed 2016-07-28) ↗ |
| Q1 2016 | Mar 31, 2016 | 1,474 | -3.3% | Form 10-Q (filed 2016-04-29) ↗ |
| Q4 2015 | Dec 31, 2015 | 1,798 | -0.1% | Form 10-K (filed 2016-02-19) ↗ |
| Q3 2015 | Sep 30, 2015 | 1,576 | -5.8% | Form 10-Q (filed 2015-10-30) ↗ |
| Q2 2015 | Jun 30, 2015 | 1,635 | -1.7% | Form 10-Q (filed 2015-07-30) ↗ |
| Q1 2015 | Mar 31, 2015 | 1,524 | +2.6% | Form 10-Q (filed 2015-04-30) ↗ |
| Q4 2014 | Dec 31, 2014 | 1,800 | – | Form 10-K (filed 2015-02-19) ↗ |
| Q3 2014 | Sep 30, 2014 | 1,672 | – | Form 10-Q (filed 2014-10-29) ↗ |
| Q2 2014 | Jun 30, 2014 | 1,664 | -10.9% | Form 10-Q (filed 2014-07-28) ↗ |
| Q1 2014 | Mar 31, 2014 | 1,485 | -10.1% | Form 10-Q (filed 2014-04-28) ↗ |
| Q2 2013 | Jun 30, 2013 | 1,868 | -3.3% | Form 10-Q (filed 2013-07-26) ↗ |
| Q1 2013 | Mar 31, 2013 | 1,652 | -10.6% | Form 10-Q (filed 2013-04-26) ↗ |
| Q4 2012 | Dec 31, 2012 | 1,978 | – | Form 10-K (filed 2013-02-21) ↗ |
| Q3 2012 | Sep 30, 2012 | 1,757 | -55.6% | Form 10-Q (filed 2012-10-26) ↗ |
| Q2 2012 | Jun 30, 2012 | 1,931 | – | Form 10-Q (filed 2012-07-27) ↗ |
| Q1 2012 | Mar 31, 2012 | 1,848 | +3.5% | Form 10-Q (filed 2012-04-30) ↗ |
| Q2 2011 | Sep 30, 2011 | 3,961 | +133.7% | Form 10-Q (filed 2011-10-28) ↗ |
| Q1 2011 | Mar 31, 2011 | 1,786 | +10.6% | Form 10-Q (filed 2011-04-29) ↗ |
| Q4 2010 | Dec 31, 2010 | 1,989 | +1.8% | Form 10-K (filed 2011-02-22) ↗ |
| Q3 2010 | Sep 30, 2010 | 1,695 | -0.4% | Form 10-Q (filed 2010-10-29) ↗ |
| Q2 2010 | Jun 30, 2010 | 1,755 | +2.8% | Form 10-Q/A (filed 2010-08-02) ↗ |
| Q1 2010 | Mar 31, 2010 | 1,614 | +5.6% | Form 10-Q (filed 2010-04-30) ↗ |
| Q4 2009 | Dec 31, 2009 | 1,953 | +13.1% | Form 10-K (filed 2010-02-22) ↗ |
| Q3 2009 | Sep 30, 2009 | 1,702 | +3.2% | Form 10-Q (filed 2009-10-30) ↗ |
| Q2 2009 | Jun 30, 2009 | 1,708 | +0.5% | Form 10-Q (filed 2009-07-31) ↗ |
| Q1 2009 | Mar 31, 2009 | 1,529 | – | Form 10-Q (filed 2010-04-30) ↗ |
| Q4 2008 | Dec 31, 2008 | 1,727 | – | Form 10-K (filed 2010-02-22) ↗ |
| Q3 2008 | Sep 30, 2008 | 1,649 | – | Form 10-Q (filed 2009-10-30) ↗ |
| Q2 2008 | Jun 30, 2008 | 1,700 | – | Form 10-Q (filed 2009-07-31) ↗ |
Cite this data
StockData. (2026). Eli Lilly Marketing, selling, and administrative ($M) ($M), quarterly Q2 2008–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_sga
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.